Navigation Links
China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
Date:8/21/2008

SHANGHAI, China, Aug. 21 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it signed a one-year contract with Henan Square Pharmaceutical Co., Ltd. ("Square Pharmaceutical") to supply probiotics for Square Pharmaceutical's probiotics-based medicines. The agreement runs through July 2009.

Square Pharmaceutical is a GMP-certified pharmaceutical company based in Henan Province. It has a portfolio of more than 60 medicines and supplements, one of which is Chang Wei Ning Capsule, a probiotics-based medicine used to improve stomach and intestinal health.

"Square Pharmaceutical marks our fifth bulk additives customer, all of which have signed contracts before we begin production at our new manufacturing facility," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "We have accelerated the pace of new customer acquisition for our additive business in preparation for launching our new plant. Currently, we are in negotiations with another 50 potential commercial customers, of which 30 have begun sample testing for their newly developed probiotics-based products. We expect our new 150-metric-ton probiotics facility to come online in the fourth quarter of 2008. We look forward to increasing the number of business customers in order to occupy the capacity of our new plant when it is up and running."

China-Biotics aims to become one of the largest probiotics suppliers in the world once the new plant starts production. During the past fiscal quarter, sales of bulk additives to commercial customers totaled $1 million, or 8.8% of sales, contributing meaningful sales for the first time.

About Henan Square Pharmaceutical Co., Ltd.

Based in Henan Province, China, Square Pharmaceutical is engaged in the development, manufacturing and distribution of pharmaceuticals and supplements. At its GMP-certified production facility, it manufactures more than 60 products.

About China-Biotics, Inc.

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company's ability to market existing and new products, ability to access to capital for expansion, and changes from anticipated levels of sales, future national or regional economic and competitive conditions, changes in relationships with customers, dependence on its flagship product profits and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:

CCG Investor Relations

Crocker Coulson, President

Phone: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgir.com


'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. China-Biotics, Inc. Files Application for Nasdaq Listing
4. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
5. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
6. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
7. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
8. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
9. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
10. China-Biotics, Inc. Completes Foundation for Its New Plant
11. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature their ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused BiOS ... InGaAs PIN diode standard packages feature a TO-46 metal can with active areas of ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... research registry built on the secure online PatientCrossroads platform, has exceeded both its ... participants have joined the PROMPT study, which seeks to advance understanding of the ...
(Date:2/10/2016)... ... 10, 2016 , ... Global Stem Cells Group, ... Global Stem Cells Network (GSCN) and its affiliate Global Medical Training Network ... adipose and bone marrow therapies. , Through the new collaboration, Global Stem ...
(Date:2/10/2016)... ... February 09, 2016 , ... Creation ... winner of the Highest Overall Customer Rating Award from Circuits Assembly , today ... units across the USA, Canada, Mexico and China. , The EMS provider, known ...
Breaking Biology Technology:
(Date:1/25/2016)... SEATTLE , Jan. 25, 2016  Glencoe Software, ... biotech, pharma and publication industries, will provide the data ... Phenotypic Screening Centre (NPSC). ... Phenotypic analysis ... even whole organisms, allowing comparisons between states such as ...
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
(Date:1/13/2016)... 2016 http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ... the  "India Biometrics Authentication & Identification ...  report to their offering.  ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ...
Breaking Biology News(10 mins):